CLINICAL_TRIALS
trial_result
· 2022-10-10
Clinical Trial Update: Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]
Summary
Phase 2 study of B244 in mild to moderate atopic dermatitis completed, results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AOBiome LLC | Conditions: Atopic Dermatitis Eczema | Phase 2 | Status: COMPLETED | Results posted: 2022-10-10